Sign In
Buy CAH
$201.74
+5.89 (+3.01%)
At Close: Jun 04, 2026
The Dividend Dynasty: 3 Stocks That Will Keep Your Pockets Lined for Years
06:56am, Monday, 10'th Jun 2024
Dividend stocks are not on everyone's radar right now, with Nvidia (NASDAQ: NVDA ) moving past Apple (NASDAQ: AAPL ) to become the second-most-valuable company in the world. And, a host of other artif
100% of Participants (n=6) With CAH Maintained Androstenedione (A4) Below the Upper Limit of Normal at all Time Points on Atumelnant (80 mg)
SAN DIEGO , June 3, 2024 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) and Diurnal Ltd., a Neurocrine Biosciences company, presented information from its neuroendocrinology pipeline at t
- CAHtalyst™ Pediatric Study Met Primary and Key Secondary Endpoints, with Crinecerfont Treatment Decreasing Androstenedione Levels and Enabling Glucocorticoid Dose Reduction While
- CAHtalyst™ Adult Phase 3 Study Met Primary and Important Key Secondary Endpoints, with Crinecerfont Treatment Decreasing Androstenedione Levels and Enabling Glucocorticoid Dose R
Cardinal Health, Inc. (CAH) Leerink Partners Healthcare Crossroads Conference (Transcript)
09:04pm, Wednesday, 29'th May 2024
Cardinal Health, Inc. (NYSE:CAH ) Leerink Partners Healthcare Crossroads Conference May 29, 2024 10:00 AM ET Company Participants Matt Sims - Head, IR Aaron Alt - CFO Conference Call Participants Mich
Here's Why Cardinal Health (CAH) is a Strong Value Stock
10:47am, Wednesday, 29'th May 2024
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Reasons to Retain Cardinal Health (CAH) in Your Portfolio Now
10:56am, Tuesday, 28'th May 2024
Cardinal Health (CAH) gains from a solid pharmaceutical segment and a diversified product portfolio. Gross margins improve.
New CAHtalyst™ Pediatric and CAHtalyst™ Adult Phase 3 Clinical Study Data in Congenital Adrenal Hyperplasia CAHtalog™ Registry Data Highlighting Impact of Supraphysiologic Glucocorticoid Dosing
Investors Heavily Search Cardinal Health, Inc. (CAH): Here is What You Need to Know
10:01am, Friday, 17'th May 2024
Cardinal (CAH) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Why Cardinal Health (CAH) is a Top Value Stock for the Long-Term
10:46am, Monday, 13'th May 2024
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Cardinal Health Board of Directors Approves Increase to Quarterly Dividend
04:15pm, Tuesday, 07'th May 2024
DUBLIN, Ohio , May 7, 2024 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved an increase to its quarterly dividend, to $0.5056 per share, out of the Comp
Woman Discovers She Is A Male After Doctors Find Testicle In Her Stomach
05:02pm, Monday, 06'th May 2024
Doctors found a testicle in her abdomen and diagnosed her with a rare disorder called Congenital Adrenal Hyperplasia (CAH)...
3 Stocks to Give You Shelter From the Coming Market Crash
02:00pm, Monday, 06'th May 2024
Sometimes the best offense is a good defense. In today's market, buying defensive stocks is probably one of the best strategies you can adopt to protect your portfolio's gains.
Here is What to Know Beyond Why Cardinal Health, Inc. (CAH) is a Trending Stock
10:01am, Monday, 06'th May 2024
Recently, Zacks.com users have been paying close attention to Cardinal (CAH). This makes it worthwhile to examine what the stock has in store.
